ARCHIVES

NIH institute directors, in response to question from Sen. Arlen Specter, say Bush Administration’s stem cell research policy is harmful to NIH leadership in science.

This article is from The Cancer Letter archive.

Vol. 31 No. 14 | April 8, 2005

Download PDF Visit The Full Archive

Related Articles

Firm Reports Limited Market For Self-Test Detection Methods

July 29, 1983

NCI Must Limit Grant Payments for Now, Until Congress Approves FY03 Budget

December 6, 2002

Seer Gets Concept Approve For Five More Years From Ad Hoc Committee Since Two PLs Are DCPC Board Members

February 3, 1984

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

April 27, 2001

NSABP Roundup: Fisher, Pitt Negotiating; 9th Chairman Candidate

October 7, 1994

Clinical Research Program Announcement

February 13, 1981